You have 9 free searches left this month | for more free features.

Melphalan

Showing 1 - 25 of 1,022

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

Not yet recruiting
  • Acute Myeloid Leukemia
  • MCBC regimen
  • Bu/Cy regimen
  • (no location specified)
Nov 13, 2023

Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)

Enrolling by invitation
  • Uveal Melanoma
  • Melphalan Injection
  • Plaque brachytherapy
  • Ribeirão Preto, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

Completed
  • Multiple Myeloma
  • Thalidomide+Melphalan +Bortezomib+stem cell transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Dec 16, 2022

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • Melphalan and Treosulfan
  • Melphalan
  • (no location specified)
Dec 5, 2022

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,

Terminated
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Delcath Hepatic Delivery System
  • Melphalan
  • Frankfurt, Germany
  • +2 more
Oct 13, 2022

Multiple Myeloma Trial in Suzhou (Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 3, 2023

Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

Active, not recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

Completed
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Multiple Myeloma Trial in Seattle (Allopurinol, Carmustine, Etoposide)

Recruiting
  • Multiple Myeloma
  • Seattle, Washington
    Swedish Cancer Institute
Jun 21, 2022

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)

Recruiting
  • Hematological Malignancy
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022

Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)

Active, not recruiting
  • Multiple Myeloma
  • Newly Diagnosed Patients
  • Melphalan
  • +2 more
  • Torino, Italy
    Division of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)

Terminated
  • Amyloidosis; Systemic
  • Propylene Glycol-Free Melphalan Hydrochloride
  • Boston, Massachusetts
    Boston Medical Center
Jul 1, 2022

Multiple Myeloma Trial in Beijing (melphalan HCl for injection)

Recruiting
  • Multiple Myeloma
  • melphalan hydrochloride for injection
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 26, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
May 9, 2023

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Washington, District of Columbia
  • +1 more
May 6, 2022

Retinoblastoma Trial in Saint Louis (Melphalan)

Active, not recruiting
  • Retinoblastoma
  • Melphalan
  • Saint Louis, Missouri
    Washington University School of Medicine (Saint Louis Children's
Jan 6, 2023

Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Fludarabine and Busulfan
  • Fludarabine and Melphalan
  • Wuhan, Hubei, China
    Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023

Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)

Not yet recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022